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Case history
A 46-year-old female presented at our depart-
ment with the onset of episodic dyspeptic symp-
toms, mainly postprandial fullness and bloating, 
as well as paresthesia. A blood test revealed 
the presence of mild macrocytic anaemia (haemo-
globin 11.3 g/dl; mean corpuscular volume 119 
fl), a reduced level of vitamin B12 (60 pmol/l; 
normal 200–750 pmol/l), hypergastrinaemia 
(1363 pg/ml; normal for female <100 pg/ml), a 
low level of pepsinogen I (<2.6 pg/ml; normal 
30–100 pg/ml), and positivity for antibodies 
against parietal cells (>1:100). The upper endos-
copy showed in oesophagus a single linear erosion 
(grade A according to Los Angeles Classification), 
with an absence of macroscopic gastric abnormal-
ities. At histology, mucosal severe atrophy with 
moderate intestinal metaplasia was found in fun-
dus and gastric corpus with spared antrum, in the 
absence of Helicobacter pylori infection. A diagno-
sis of autoimmune gastritis with pernicious anae-
mia was therefore made, and the patient started 
vitamin B12 intramuscular injections. Due to the 
absence of specific symptoms such as heartburn 
and/or regurgitation and to the presence of auto-
immune gastritis, the erosive oesophagitis was not 
treated. After 4 weeks of treatment with vitamin 
B12, the haemoglobin, mean corpuscular volume 
and vitamin B12 values were restored, paresthesia 
improved, while dyspepsia remained stable, with 
sporadic symptoms about once a week.
The patient was affected from the age of 16 by 
Hashimoto’s thyroiditis under treatment with 
levothyroxine (100 μg daily). Two or three times 
a month she took nonsteroidal anti-inflammatory 
drugs for headache. She presented a family his-
tory of autoimmune diseases, with her sister being 
affected by autoimmune thyroid disease and 
her brother by vitiligo, while no family history 
of gastrointestinal diseases was reported. The 
patient’s body mass index was 24.4 kg/m2 (55 kg; 
150 cm). She was a nonsmoker. She did not 
undergo abdominal surgery.
The dyspeptic symptoms remained stable in inten-
sity and frequency for about 2 years, after which the 
patient experienced a progressive worsening of dys-
peptic symptoms, with daily early satiety and onset 
of augmented salivation, troublesome nausea with 
sporadic vomiting (mostly post-prandial), and tho-
racic pain. The results of a physical examination 
and abdominal ultrasound were unremarkable. To 
investigate this new pattern of symptoms a second 
endoscopy was performed, 3 years after the first. A 
short tongue of columnar lined mucosa (1 cm) was 
detected at distal oesophagus, and at histology a 
focal area of intestinal metaplasia without dysplasia 
was found, confirming the presence of Barrett’s 
oesophagus. At histology, the severe mucosal atro-
phy with intestinal metaplasia in fundus and corpus 
was confirmed. Treatment with domperidone (10 
mg three times a day) was undertaken with a partial 
reduction of symptoms, mainly the nausea, vomit-
ing and dyspepsia, but it was interrupted after the 
onset of breast pain. Due to the persistence of trou-
blesome dyspepsia, a further endoscopy was per-
formed about 6 months later. During the endoscopy 
a spot sample of gastric juice was titrated, showing 
a pH of 7.5. The presence of metaplastic columnar 
epithelium at distal oesophagus (C0 M1, according 
to Prague Classification) with intestinal metaplasia, 
and fundus/corpus severe atrophy were recon-
firmed, thus providing new strong evidence of the 
coexistence of pernicious anaemia and Barrett’s 
oesophagus. A new abdominal ultrasound gave 
unremarkable findings.
To assess the presence of reflux or oesophageal 
dysmotility, a 24-hour pH-impedance measure-
ment and a high-resolution oesophageal manom-
etry was performed. The pH data showed an 
acid exposure time of 0% and no acid reflux epi-
sodes were identified. The DeMeester score 
was 0.8% (normal value <14.7%). The median 
value of registered intragastric pH was 6.56. 
Analysis of impedance signals showed 30 epi-
sodes of reflux, 20 of weakly acidic, 9 of gas 
weakly acidic and 1 of gas weakly alkaline. 
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Proximal extent of reflux was detected in 12 
refluxes. A positive symptom index and symp-
tom association probability for weakly acid reflux 
(50% and 100%, respectively) were found. A 
high-resolution manometry demonstrated a 
normotonic lower oesophageal sphincter (23.3 
mmHg), in the absence of significant alterations 
of oesophageal motility.
Treatment with alginic acid was undertaken up to 
now, with benefits in terms of the augmented sali-
vation, nausea and thoracic pain, but the dyspep-
tic symptoms persisted, mainly epigastric pain, 
which occurred about twice a week. A follow-up 
endoscopy (with narrow band imaging) was per-
formed, 6 years after the diagnosis of autoim-
mune gastritis, and 3 years after that of Barrett’s 
oesophagus. The short Barrett’s oesophagus (C0 
M1) with intestinal metaplasia and the atrophic 
gastritis was still confirmed (Figure 1).
Discussion
This case report shows for the first time the unu-
sual copresence of two conditions: autoimmune 
atrophic gastritis with pernicious anaemia, and 
Barrett’s oesophagus, contrasting with the com-
mon belief that these two conditions are mutually 
exclusive. In this hypochlorhydric patient, we 
documented conditions associated with gastro-
oesophageal reflux disease (GORD), from a mild 
erosive oesophagitis to the Barrett’s oesophagus, 
during a follow up of 6 years. Both erosive 
oesophagitis and Barrett’s oesophagus are consid-
ered acid-related conditions, and it has been 
reported that patients with Barrett’s oesophagus 
have a greater degree of oesophageal acid expo-
sure than patients with erosive oesophagitis, non-
erosive reflux disease, or is the case with normal 
subjects [Loughney et al. 1998; Fass et al. 2001; 
Martinez et  al. 2003]. In this case, impedance 
pH-metry revealed that acid exposure time and 
acid reflux episodes were absent, and an analysis 
of impedance signals showed the presence of 
weakly acidic refluxes, suggesting that this type of 
reflux is able to induce oesophageal mucosal 
inflammation, even Barrett’s damage. Currently, 
the role of weakly acidic reflux alone in Barrett’s 
oesophagus is not established. Farré and col-
leagues demonstrated that oesophageal perfusion 
with weakly acidic solutions provoked identical 
changes as those observed after perfusion with 
acid solutions, in terms of dilated intercellular 
spaces [Farré et al. 2010]. However, it should be 
kept in mind that weakly acidic reflux covers a 
wide pH range, between 4 and 7, and the patho-
genic role of the different pH values in GORD 
and its complications is not defined.
Accurate research concerning GORD and its 
complications associated with pernicious anaemia 
has been made, and a few related articles have 
been found. In a 1960 article, 22 patients with 
documented achlorhydria of different aetiology, 
from atrophic gastritis to gastrectomy, reported 
an endoscopic diagnosis of erosive oesophagitis 
[Palmer, 1960]. In 2006, a single case report 
described the combination of autoimmune gastritis 
with pernicious anaemia and gastro-oesophageal 
reflux symptoms, due to weakly acidic and 
weakly alkaline refluxes [Bredenoord et al. 2006]. 
However, this patient had undergone cholecys-
tectomy a few years earlier, and this may have 
facilitated the entry of bile into the stomach. The 
role of the bile reflux in the development of heart-
burn was also described in another case of perni-
cious anaemia, and the authors described the 
resolution of symptoms through the use by the 
patient of cholestyramine [Orlando and Bozymski, 
1973]. Although our patient did not undergo gall-
bladder surgery, she had one gas weakly alkaline 
reflux, but we believe that bile reflux played only 
a minor role in this case of Barrett’s oesophagus.
Finally, a 2016 paper by Tenca and colleagues 
investigates, for the first time, the presence of 
GORD with pH-impedance monitoring in a 
notable cohort of patients affected by chronic 
autoimmune gastritis [Tenca et  al. 2016]. The 
study notes that 24% of patients were found as 
GORD positive at pH-impedance monitoring, 
Figure 1. Endoscopic image of a tongue of columnar 
lined mucosa at distal oesophagus, the classical 
presentation of Barrett’s oesophagus.
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confirming the occurrence of this phenomenon in 
autoimmune gastritis. Interestingly, no differ-
ences in pH-impedance parameters were observed 
between symptomatic and asymptomatic patients. 
Moreover, the long-term antisecretory treatment 
(both proton-pump inhibitors and H2 antago-
nists) did not influence control of the symptoms, 
indicating the inappropriate prescription of these 
drugs in autoimmune gastritis with GORD symp-
toms. However, no information about endoscopic 
oesophageal findings was given.
In the literature, a strong negative association 
has been reported between severe gastric atro-
phy and both reflux oesophagitis (OR 0.17) and 
Barrett’s oesophagus (OR 0.13) [Anderson et al. 
2008]. This observation is consistent with the 
role of gastric acid secretion in the development 
of oesophagitis and Barrett’s oesophagus, and 
consequently a reduction of acidic secretion had 
a protective role against these conditions. Our 
patient presents many supposed protective fac-
tors against Barrett’s oesophagus, i.e. absence 
of acid reflux, normotonic lower oesophageal 
sphincter, normal oesophageal motility, female 
gender, normal weight, no smoking and no fam-
ily history of Barrett’s oesophagus. The eventual 
presence of delayed gastric emptying should be 
considered as a possible factor which might have 
contributed to the development of oesophageal 
reflux. In fact, it has been demonstrated that 
achlorhydria and an increased gastrin serum 
level are associated with a delayed gastric 
emptying of solid meals [Tosetti et  al. 2000]. 
This clinical case presents an unsolved question 
about the treatment choices. These are very lim-
ited, since no medications are available for non-
acid reflux. Prokinetics may represent an option, 
but the patient presented adverse effects; how-
ever, treatment with alginic acid has been 
undertaken with a partial resolution of symp-
toms. This case report suggests that Barrett’s 
oesophagus may originate even in a hypochlo-
rhydric patient, strengthening the hypothesis 
that acid is not the sole culprit of oesophageal 
damage.
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